Ultrastructural and biochemical alterations of livers from rats treated with 5,5-diphenyl-2-thiohydantoin (DPTH) and thyroxine.
D000090:Acetoacetates / Q000096:biosynthesis; D000818:Animals; D002210:Caprylates / Q000378:metabolism; D002331:Carnitine / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000187:drug effects; D005227:Fatty Acids / Q000378:metabolism; D006885:Hydroxybutyrates / Q000096:biosynthesis; D050356:Lipid Metabolism; D008099:Liver / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects*; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D009929:Organ Size; D010672:Phenytoin / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D013440:Sulfides / Q000494:pharmacology; D013974:Thyroxine / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000090:Acetoacetates; D002210:Caprylates; D005227:Fatty Acids; D006885:Hydroxybutyrates; D008112:Liver Glycogen; D011506:Proteins; D013440:Sulfides; D010672:Phenytoin; D012313:RNA; D004247:DNA; D013974:Thyroxine; D002331:Carnitine